Amit Sachdev - 10 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2022
Net transactions value
-$592,210
Form type
4
Filing time
14 Feb 2022, 15:20:00 UTC
Previous filing
03 Feb 2022
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $592,210 -2,491 -4% $237.74 59,075 10 Feb 2022 Direct
holding VRTX Common Stock 882 10 Feb 2022 401(k)
holding VRTX Common Stock 15,573 10 Feb 2022 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.